Printing the Future of Therapeutics in 3D
May 2022 at the
Peter Wall Institute for Advanced Studies
Vancouver, BC, Canada
FOSTERING RELATIONSHIPS AND DEVELOPING COLLABORATIONS
PFT3D is an exclusive roundtable event centred around facilitating discussion and collaboration on the development of commercially and clinically relevant life-saving tissues.
Aspect Biosystems and The University of British Columbia are proud to be co-organizing the fourth annual international symposium on Printing the Future of Therapeutics in 3D (PFT3D).
Last year’s inaugural event saw speakers from a wide variety of both academia and industry to discuss the amazing potential and applications of 3D bioprinting. This year, the event will take place over 3 days and includes 20 speakers, covering four key areas:
Functional biofabricated tissues for disease modeling, therapeutic discovery, and regenerative medicine
Platform technologies to recreate biological function
Biomaterials for the development of functional tissues
An industry perspective on tissue engineering technologies
By the end of this meeting, we want you to leave with new inspirational ideas on groundbreaking projects, new partners and opportunities for collaboration, and a fresh perspective on the needs of industry and the translation of academic research.
In addition to our roundtable talks, there will be focused discussion sessions to address a variety of key challenges in our industry and facilitated networking sessions to stimulate interactions.
2020 SPEAKERS & PANELLISTS
(more to be announced)
Speakers & Panellists
2019 SPEAKERS & PANELLISTS
- Nureddin Ashammakhi
Co-Director, Institute for Minimally Invasive Therapeutics, David Geffen School of Medicine, UCLA
- R. Lee Buckler
President & CEO, RepliCel Life Sciences, Inc.
- Heather Burkin
Assistant Professor, Department of Pharmacology University of Nevada, Reno School of Medicine
- Jason Ekert
Head Complex In Vitro Models, In Vitro/In Vivo Translation, Research, GlaxoSmithKline
- Spiro Getsios
VP, Tissue Engineering, Aspect Biosystems
- Paul C. Goodwin
Science Director, GE Healthcare, Life Sciences
- Ken-ichi Hamada
Program Manager, JSR-Keio University Medical and Chemical Innovation Center, JSR Corporation
- Jinah Jang
Assistant Professor, Pohang University of Science and Technology (POSTECH)
- Anna Jezierski
Research Scientist, Human Health Therapeutics, National Research Council Canada
- Timothy J. Kieffer
Professor, Cellular & Physiological Sciences and Surgery, University of British Columbia, Diabetes Research Group Leader, School of Biomedical Engineering, Life Sciences Institute
- Todd A. Lorenz
Partner, Intellectual Property & Technology, Squire Patton Boggs
- Faisal M. Mirza
Surgeon, Artist, Author, Entrepreneur, OrthoSynthesis Inc.
- Carlos Mota
Assistant Professor, Maastricht University, MERLN Institute, Dept. of Complex Tissue Regeneration, The Netherlands
- Massimiliano Paganelli
Pediatric Hepatologist, Sainte-Justine University Hospital Center, Assistant Professor of Pediatrics, Université de Montréal, Founder, Morphocell Technologies Inc.
- Fabio Rossi
Professor, Medical Genetics and Biomedical Engineering, University of British Columbia, Director of the Biomedical Research Centre and Director of Research of the School of Biomedical Engineering
- Venu Varanasi
Associate Professor, Department of Graduate Nursing, Department of Materials Science and Engineering, University of Texas at Arlington
- Adrian West
Assistant Professor, Department of Physiology and Pathophysiology, University of Manitoba
- Stephanie Willerth
Associate Professor and Canada Research Chair in Biomedical Engineering, University of Victoria
- Tim Woodfield
Assoc Professor, University of Otago, New Zealand Director CReaTE Group, Department of Orthopaedic Surgery Director UOtago Centre for Bioengineering & Nanomedicine
- Yu Shrike Zhang
Assistant Professor, Department of Medicine, Harvard Medical School
Over the two days, we will have influential innovators from around the world discussing the latest technological advances and challenges of bioprinting living human tissues.
Last year’s program can be downloaded HERE.
Monday, May 4
5:00pm: Welcome Reception – Downtown Vancouver
Tuesday, May 5
8:15-9:00am: Breakfast & Registration
9:00-4:00pm: Talks & Interactive Discussion
5:00pm: informal eats and drinks on campus OR
shuttle departs for Speakers’ Reception (invite only)
Wednesday, May 6
9:00am onward: Talks, Panel & Interactive Discussion
Late afternoon: Close of PFT3D 2020 (exact time TBA)
VENUE & HOSTS
We are proud to be hosting this International Research Roundtable at the Peter Wall Institute for Advanced Studies on the beautiful University of British Columbia (UBC) campus in Vancouver, BC.
Aspect Biosystems is a privately held biotechnology company pioneering microfluidic 3D bioprinting of living, human tissue. The company’s proprietary technology is enabling advances in understanding fundamental biology, disease research, development of novel therapeutics, and regenerative medicine. In addition to its internal programs, Aspect is focused on strategically partnering with pharmaceutical and biotechnology companies, as well as academic researchers, to enable the creation of living, human tissues for medical research, therapeutic discovery, and regenerative medicine products.
The School of Biomedical Engineering at the University of British Columbia was established in 2017. We are founded through partnerships with more than 20 joint faculty members that are leaders in research areas from molecular and cellular engineering, to biological imaging, computational biology and human interfacing devices. With access to world-leading research infrastructure, and with close partnerships with our research intensive hospitals and local industry, the School aims to provide a clear route from the discovery of new fundamental biomedical technologies to their innovative application and development to benefit human health.
The University of British Columbia is a global centre for research and teaching, consistently ranked among the 40 best universities in the world. Since 1915, UBC’s West Coast spirit has embraced innovation and challenged the status quo. Its entrepreneurial perspective encourages students, staff and faculty to challenge convention, lead discovery and explore new ways of learning. At UBC, bold thinking is given a place to develop into ideas that can change the world.
The Peter Wall Institute for Advanced Studies at the University of British Columbia (UBC) provides funding opportunities and an intellectual environment scholars are free to pursue the collaborative exchange of ideas beyond disciplinary boundaries.
The Institute’s goal is to stimulate creative, innovative research that makes important advances in knowledge, and to share or implement these ideas through ongoing community engagement. The Institute achieves this by supporting a highly collaborative environment at UBC where scholars have the opportunity to exchange ideas with national and international scholars, develop new thinking and engage in intellectual risk-taking.